The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa

Background: Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus pat...

Full description

Bibliographic Details
Main Authors: William Mhundwa, Gina Joubert, Thabiso R. Mofokeng
Format: Article
Language:English
Published: AOSIS 2023-05-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/5663
_version_ 1797788724297203712
author William Mhundwa
Gina Joubert
Thabiso R. Mofokeng
author_facet William Mhundwa
Gina Joubert
Thabiso R. Mofokeng
author_sort William Mhundwa
collection DOAJ
description Background: Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus patients who develop CKD are likely to be excluded from chronic dialysis and rely on control of risk factors, including blood pressure and blood glucose levels, to prevent CKD progression. We aimed to determine the prevalence of CKD among T2DM patients attending the diabetes clinic at Pelonomi Academic Hospital, Bloemfontein. Methods: In this retrospective cross-sectional study, medical records of patients (January 2016 and December 2018) were reviewed to collect demographic and clinical information. Results: In total, 244 records were reviewed. Sixty-one (25.0%, 95% confidence interval [CI]: 20% – 30.8%) T2DM patients had CKD. The rate of CKD was slightly higher in males (n = 24/81; 29.6%) compared with females (n = 37/163; 22.7%). Most patients with CKD (n = 58; 95.1%) were 50 years of age. Only 17.8% of patients achieved a glycosylated haemoglobin (HbA1c) of 7.0%. Blood pressure was controlled in 14.3% of hypertensive patients. Renin–angiotensin–aldosterone system inhibitors were used by 78.6% of patients. Conclusion: A high prevalence of clinically significant CKD among T2DM patients with poor prospects of chronic dialysis in a resource-limited setting was observed. The risk factors for CKD development and progression should be adequately managed in T2DM patients. Contribution: This study emphasises the need for further research and innovation to improve outcomes of T2DM patients with CKD in resource-constrained settings.
first_indexed 2024-03-13T01:40:34Z
format Article
id doaj.art-4386bcad0fca4fed99a47e19015b7f42
institution Directory Open Access Journal
issn 2078-6190
2078-6204
language English
last_indexed 2024-03-13T01:40:34Z
publishDate 2023-05-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj.art-4386bcad0fca4fed99a47e19015b7f422023-07-03T14:07:41ZengAOSISSouth African Family Practice2078-61902078-62042023-05-01651e1e610.4102/safp.v65i1.56634336The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South AfricaWilliam Mhundwa0Gina Joubert1Thabiso R. Mofokeng2Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, BloemfonteinDepartment of Biostatistics, School of Biomedical Sciences, Faculty of Health Sciences, University of the Free State, BloemfonteinDepartment of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, BloemfonteinBackground: Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD). The prevalence of CKD among T2DM patients in Africa is 22.0%. The cut-off age for dialysing diabetic patients in the resource-limited state sector in South Africa is 50 years. Type 2 diabetes mellitus patients who develop CKD are likely to be excluded from chronic dialysis and rely on control of risk factors, including blood pressure and blood glucose levels, to prevent CKD progression. We aimed to determine the prevalence of CKD among T2DM patients attending the diabetes clinic at Pelonomi Academic Hospital, Bloemfontein. Methods: In this retrospective cross-sectional study, medical records of patients (January 2016 and December 2018) were reviewed to collect demographic and clinical information. Results: In total, 244 records were reviewed. Sixty-one (25.0%, 95% confidence interval [CI]: 20% – 30.8%) T2DM patients had CKD. The rate of CKD was slightly higher in males (n = 24/81; 29.6%) compared with females (n = 37/163; 22.7%). Most patients with CKD (n = 58; 95.1%) were 50 years of age. Only 17.8% of patients achieved a glycosylated haemoglobin (HbA1c) of 7.0%. Blood pressure was controlled in 14.3% of hypertensive patients. Renin–angiotensin–aldosterone system inhibitors were used by 78.6% of patients. Conclusion: A high prevalence of clinically significant CKD among T2DM patients with poor prospects of chronic dialysis in a resource-limited setting was observed. The risk factors for CKD development and progression should be adequately managed in T2DM patients. Contribution: This study emphasises the need for further research and innovation to improve outcomes of T2DM patients with CKD in resource-constrained settings.https://safpj.co.za/index.php/safpj/article/view/5663chronic kidney diseasetype 2 diabetes mellitusend-stage renal diseasediabetic kidney diseaserisk factorscontrolalbuminuriarenin-angiotensin-aldosterone system
spellingShingle William Mhundwa
Gina Joubert
Thabiso R. Mofokeng
The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
South African Family Practice
chronic kidney disease
type 2 diabetes mellitus
end-stage renal disease
diabetic kidney disease
risk factors
control
albuminuria
renin-angiotensin-aldosterone system
title The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
title_full The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
title_fullStr The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
title_full_unstemmed The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
title_short The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa
title_sort prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central south africa
topic chronic kidney disease
type 2 diabetes mellitus
end-stage renal disease
diabetic kidney disease
risk factors
control
albuminuria
renin-angiotensin-aldosterone system
url https://safpj.co.za/index.php/safpj/article/view/5663
work_keys_str_mv AT williammhundwa theprevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica
AT ginajoubert theprevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica
AT thabisormofokeng theprevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica
AT williammhundwa prevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica
AT ginajoubert prevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica
AT thabisormofokeng prevalenceofchronickidneydiseaseamongtype2diabetesmellituspatientsincentralsouthafrica